Clinical analysis of intraosseous curettage combined with decompression in the treatment of mandibular solid ameloblastoma: report of 24 consecutive cases

doi:10.19438/j.cjoms.2021.03.015

Abstract

Abstract: PURPOSE: To evaluate the effect of intraosseous curettage combined with decompression using for mandibular solid ameloblastoma treatment. METHODS: Twenty-four cases with unilocular or multilocular solid ameloblastoma of the mandible received intraosseous curettage combined with decompression from Jan. 2017 to Dec. 2018. The primary evaluation parameter was the percentage of the residual cyst area within 1-year follow-up after surgery. RESULTS: A total of 24 cases were included in this study. After 12-24 months of consecutive follow-up, the tumor cavities shrank to different extent without recurrence and osteogenesis was good. Compared with preoperative panorama and CT scan, six cases were ranked as no response (stable), ten were partial response and the remaining eight cases were classified as complete response. The overall efficiency was 75.0%. CONCLUSIONS: Intraosseous curettage combined with decompression is an effective therapeutic method for solid ameloblastoma of the mandible.

Key words: Curettage and decompression, Mandible, Solid ameloblastoma

CLC Number:

R739.8

HE Jie, TIAN Zhuo-wei, HU Yong-jie, WANG Yan-an. Clinical analysis of intraosseous curettage combined with decompression in the treatment of mandibular solid ameloblastoma: report of 24 consecutive cases[J]. China Journal of Oral and Maxillofacial Surgery, 2021, 19(3): 258-261.

References

[1] Hendra FN, Van Cann EM, Helder MN, et al.Global incidence and profile of ameloblastoma: a systematic review and meta-analysis[J]. Oral Dis, 2020, 26(1): 12-21.
[2] Neagu D, Escuder-de la Torre O, Vázquez-Mahía I, et al. Surgical management of ameloblastoma. Review of literature[J]. J Clin Exp Dent, 2019, 11(1): e70-e75.
[3] McClary AC, West RB, McClary AC, et al. Ameloblastoma: a clinical review and trends in management[J]. Eur Arch Otorhinolaryngol, 2016, 273(7): 1649-1661.
[4] 黄洪章, 曾东林, 张彬, 等. 成釉细胞瘤研究进展[J]. 中国口腔颌面外科杂志, 2005, 3(4): 273-278.
[5] Hendra FN, Natsir Kalla DS, Van Cann EM, et al.Radical vs conservative treatment of intraosseous ameloblastoma: systematic review and meta-analysis[J]. Oral Dis, 2019, 25(7): 1683-1696.
[6] Yang Z, Liang Q, Yang L, et al.Marsupialization of mandibular cystic ameloblastoma: retrospective study of 7 years[J]. Head Neck, 2018, 40(10): 2172-2180.
[7] Haq J, Siddiqui S, McGurk M. Argument for the conservative management of mandibular ameloblastomas[J]. Br J Oral Maxillofac Surg, 2016, 54(9): 1001-1005.
[8] Ghandhi D, Ayoub AF, Pogrel MA, et al.Ameloblastoma: a surgeon's dilemma[J]. J Oral Maxillofac Surg, 2006, 64(7): 1010-1014.
[9] Dhanuthai K, Chantarangsu S, Rojanawatsirivej S, et al.Ameloblastoma: a multicentric study[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2012, 113(6): 782-788.
[10] Koukourakis GV, Miliadou A, Sotiropoulou-Lontou A.Ameloblastoma, a rare benign odontogenic tumour: an interesting tumour review targeting the role of radiation therapy[J]. Clin Transl Oncol, 2011, 13(11): 793-797.
[11] Carlson ER, Marx RE.The ameloblastoma: primary, curative surgical management[J]. J Oral Maxillofac Surg, 2006, 64(3): 484-494.
[12] Williams TP.Management of ameloblastoma: a changing perspective[J]. J Oral Maxillofac Surg, 1993, 51(10): 1064-1070.
[13] Vered M, Muller S, Heikinheimo K.Ameloblastoma[C]// El-Naggar AK, Chan JKC, Grandis JR, et al. WHO classification of head and neck tumours[M]. IARC, Lyon: International Agency for Research on Cancer, 2017: 215-218.
[14] Feinberg SE, Steinberg B.Surgical management of ameloblastoma. Current status of the literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1996, 81(4): 383-388.
[15] Siar CH, Lau SH, Ng KH.Ameloblastoma of the jaws: a retrospective analysis of 340 cases in a Malaysian population[J]. J Oral Maxillofac Surg, 2012, 70(3): 608-615.
[16] Oginni FO, Stoelinga PJ, Ajike SA, et al.A prospective epidemiological study on odontogenic tumours in a black African population, with emphasis on the relative frequency of ameloblastoma[J]. Int J Oral Maxillofac Surg, 2015, 44(9): 1099-1105.
[17] Milman T, Ying GS, Pan W, et al.Ameloblastoma: 25 year experience at a single institution[J]. Head Neck Pathol, 2016, 10(4): 513-520.
[18] Luo HY, Li TJ.Odontogenic tumors: a study of 1309 cases in a Chinese population[J]. Oral Oncol, 2009, 45(8): 706-711.
[19] Kreppel M, Zöller J.Ameloblastoma-clinical, radiological, and therapeutic findings[J]. Oral Dis, 2018, 24(1-2): 63-66.
[20] Sham E, Leong J, Maher R, et al.Mandibular ameloblastoma: clinical experience and literature review[J]. ANZ J Surg, 2009, 79(10): 739-744.
[21] Nakamura N, Higuchi Y, Tashiro H, et al.Marsupialization of cystic ameloblastoma: a clinical and histopathologic study of the growth characteristics before and after marsupialization[J]. J Oral Maxillofac Surg, 1995, 53(7): 748-754.